The Valley Desk

NCT04704921 · Interventional trial

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

Overall registry status Active not recruiting

Phase 2 · Phase 3

Conditions AMD, CNV, Choroidal Neovascularization, Neovascular AMD, Neovascular Age-related Macular Degeneration, Wet AMD, Wet Age-related Macular Degeneration, nAMD, wAMD

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov